These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9755881)

  • 1. Chitosan and its use as a pharmaceutical excipient.
    Illum L
    Pharm Res; 1998 Sep; 15(9):1326-31. PubMed ID: 9755881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of chitin and chitosan derivatives in the pharmaceutical field.
    Kato Y; Onishi H; Machida Y
    Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitin and chitosan as direct compression excipients in pharmaceutical applications.
    Badwan AA; Rashid I; Omari MM; Darras FH
    Mar Drugs; 2015 Mar; 13(3):1519-47. PubMed ID: 25810109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based Polymer Matrix for Pharmaceutical Excipients and Drug Delivery.
    Khan MIH; An X; Dai L; Li H; Khan A; Ni Y
    Curr Med Chem; 2019; 26(14):2502-2513. PubMed ID: 30259805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan: some pharmaceutical and biological aspects--an update.
    Singla AK; Chawla M
    J Pharm Pharmacol; 2001 Aug; 53(8):1047-67. PubMed ID: 11518015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
    Bernkop-Schnürch A
    Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
    AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.
    Senel S; Ikinci G; Kaş S; Yousefi-Rad A; Sargon MF; Hincal AA
    Int J Pharm; 2000 Jan; 193(2):197-203. PubMed ID: 10606782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Hormonal Tablets Disintegration: The Role of Chitosan as an Alternative Disintegrant in Estradiol Tablet Formulation.
    Sembiring MH; Riadi T; Arsyadi
    Int J Pharm Compd; 2024; 28(5):432-439. PubMed ID: 39405572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel superdisintegrating agent made from physically modified chitosan with silicon dioxide.
    El-Barghouthi M; Eftaiha A; Rashid I; Al-Remawi M; Badwan A
    Drug Dev Ind Pharm; 2008 Apr; 34(4):373-83. PubMed ID: 18401779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylated chitosan: hydrophobic matrices for controlled drug release.
    Le Tien C; Lacroix M; Ispas-Szabo P; Mateescu MA
    J Control Release; 2003 Nov; 93(1):1-13. PubMed ID: 14602417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
    Chandy T; Rao GH; Wilson RF; Das GS
    Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential aspects of chitosan as pharmaceutical excipient.
    Ray SD
    Acta Pol Pharm; 2011; 68(5):619-22. PubMed ID: 21928704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules.
    Säkkinen M; Seppälä U; Heinänen P; Marvola M
    Eur J Pharm Biopharm; 2002 Jul; 54(1):33-40. PubMed ID: 12084500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of chitosan for sustained-release preparations of water-soluble drugs.
    Sawayanagi Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4213-5. PubMed ID: 7165883
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical application of biomedical polymers. XXIX. Preliminary study on film dosage form prepared from chitosan for oral drug delivery.
    Miyazaki S; Yamaguchi H; Takada M; Hou WM; Takeichi Y; Yasubuchi H
    Acta Pharm Nord; 1990; 2(6):401-6. PubMed ID: 2095798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.